A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

NCT04521023 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Cantabell Tab
DRUG: Candemore Plus Tab

Sponsor

Chong Kun Dang Pharmaceutical